Injective Partners with BDACS for Korean Won Stablecoin Integration
Injective Protocol collaborates with BDACS to introduce a Korean won-backed stablecoin into its real-world asset ecosystem.
Injective Protocol collaborates with BDACS to introduce a Korean won-backed stablecoin into its real-world asset ecosystem. Injective (INJ) is trading at ₹844 ($8.88), up 2.1% since this brief published. This is an original Token Times brief based on reporting by The Block, with live market data added, as of Tue, 20 Oct 2026 15:00:01 UTC.
This partnership aims to bridge traditional finance with crypto by integrating a fiat-backed stablecoin, potentially increasing adoption and liquidity in South Korea's crypto market amid evolving regulations.
- Injective partners with BDACS for Korean won stablecoin integration.
- Move aligns with South Korea's stablecoin regulatory developments.
- INJ token up 3.45% in 24 hours amid broader market stability.
- Injective Expands Stablecoin Access with New USDC Transfer Route
- Injective Partners with BDACS for Korean Won Stablecoin Integration — this brief
Injective Protocol has announced a partnership with BDACS to integrate a Korean won-backed stablecoin into its platform. This move is part of Injective's strategy to expand its real-world asset (RWA) ecosystem by incorporating fiat-backed stablecoins.
The collaboration comes as South Korea is actively working on creating a regulatory framework for stablecoins denominated in the Korean won. This regulatory development is crucial for the integration and acceptance of such digital assets within the country's financial system.
The partnership with BDACS is significant as it aims to bridge the gap between traditional finance and the crypto market. By introducing a won-backed stablecoin, Injective could attract more users and increase liquidity in the South Korean market.
Injective's native token, INJ, has seen a 3.45% increase in the past 24 hours, currently trading at $8.7, with a market cap of $870.2 million. This price movement suggests positive market sentiment towards the partnership, especially as the broader crypto market remains relatively flat.
The integration of a Korean won stablecoin could pave the way for further adoption of crypto in South Korea. Investors and users will likely watch for regulatory updates and the stablecoin's performance once it is launched.
Since this brief published about 1 hour ago, Injective (INJ) has moved from ₹826.96$8.70 to ₹844.07$8.88 — +2.07%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₹924.85 (about $8.88), up 4.6% over 24 hours. The rupee itself trades about 9.6% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Figures and sectors in this story, checked live against on-chain aggregators · October 20, 2026.
Token Times reads these figures directly from on-chain aggregators (DeFiLlama, mempool.space) at build time — independent of what any outlet reported. Sector totals aggregate every protocol DeFiLlama tracks in that category. Values are live and will change.
Injective Partners with BDACS for Korean Won Stablecoin Inte — questions & answers
What is the purpose of the Injective-BDACS partnership?
The partnership aims to integrate a Korean won-backed stablecoin into Injective's ecosystem, bridging traditional finance with crypto.
How does this affect the broader crypto market?
The move could increase adoption and liquidity in South Korea's crypto market, potentially influencing regional crypto dynamics.
What is the current market reaction to the news?
INJ token has risen 3.45% in the past 24 hours, indicating positive market sentiment towards the partnership.
How much is 1 Injective worth in rupee today?
About ₹924.85 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $8.88. The rupee price moves with both INJ's US-dollar price and the USDT/INR rate; use our Injective in rupee page for any amount.
Has Injective's price moved since this brief was published?
INJ is up 2.07% since this brief first published — trading at ₹844 ($8.88) now versus ₹827 ($8.70) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from The Block. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.